期刊文献+

糖皮质激素降阶梯疗法治疗160例慢性湿疹的临床疗效分析 被引量:5

Clinical curative effect analysis of chronic eczema cured by Glucocorticoids drop step treatment
下载PDF
导出
摘要 目的探讨糖皮质激素降阶梯疗法治疗慢性湿疹的临床治疗效果。方法随机抽取2010—2011年在该院治疗慢性湿疹的患者160例,随机分为干预组和对照组,其中对照组分为甲、乙、丙三组。对干预组采用糖皮质激素降阶梯疗法进行治疗。对对照组中甲、乙、丙三组分别采用复方丙酸氯倍他索软膏治疗、糠酸莫米松软膏和氟芬那酸丁酯软膏进行治疗。结果干预组中患者的治疗效果与甲组相当,并且效果较之于乙组、丙组有明显优势;干预组中患者的不良反明显低于甲组患者,较之于乙组、丙组不良反应无统计学意义。结论糖皮质激素降阶梯疗法对治疗慢性湿疹治疗效果好,并且不良反应少。 Objective Analysis of glucocorticoid effect of de-escalation therapy in treatment of chronic eczema. Methods 2010- 2011 randomly in 160 cases of chronic eczema treated in our hospital, were randomly assigned to intervention and control groups, which are divided into three groups a, b and c in the control group. De-escalation therapy with glucocorticoid used in the inter- vention group for treatment. In the control group a, b, c three group use clobetasol propionate with betamethasone ointment in treating and mometasone Furoate ointment and butyl fluoride mefenamic acid ointment for treatment. Results Therapeutic effect and a group of patients in the intervention group, and effects than in Group b, group c has a clear advantage; poor patients in the intervention group patients with anti-significantly lower than a group compared to the adverse reactions of Group b, group c was not statistically significant. Conclusion Glucocorticoid effect of de-escalation therapy in treatment of chronic eczema treated with good effect, and fewer adverse reactions.
作者 黄雪梅
出处 《中外医疗》 2013年第4期14-14,16,共2页 China & Foreign Medical Treatment
关键词 糖皮质激素 降阶梯疗法 慢性湿疹 临床疗效 Glucocorticoid De-escalation therapy Chronic Eczema Clinical curative effect
  • 相关文献

参考文献5

二级参考文献45

  • 1王霞,邓加.苦参洗剂冷湿敷治疗面部湿疹皮炎的护理观察[J].中国误诊学杂志,2009,9(2):317-318. 被引量:5
  • 2金丽威,鲁智勇,郑捷.抗不同细胞核成分抗体与SLE病情活动不相关[J].中华皮肤科杂志,2004,37(9):509-511. 被引量:4
  • 3王文慧,李邻峰,路雪艳.0.1%糠酸莫米松乳膏治疗小儿皮炎、湿疹多中心临床观察[J].临床皮肤科杂志,2003,32(12):741-742. 被引量:18
  • 4Yildirim M,Kilin(c) N,Oktay MF,et al.A case of solitary angiokeratoma circumscriptum of the tongue[J].Kulak Burun Bogaz Ihtis Derg,2007,17(6):333-335.
  • 5Primavera A, Audenino D, Mavilio N, et al. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis[J].Ann Rheum Dis, 2001, 60(5): 534-537.
  • 6郑捷 许以平 郑捷.结缔组织疾病[A].许以平,郑捷.现代免疫学检验与临床实践[M].上海:上海科技文献出版社,1999.61-101.
  • 7Futei Y, Amagai M, Ishii K, et al. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus[J]. J Dermatol Sci, 2001, 26(1): 55-61.
  • 8Schacke H, Schottelius A, Docke WD, et al. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects[J]. Proc Natl Acad Sci U S A, 2004, 101(1): 227-232.
  • 9Buttgereit F, da Silva JA, Boers M, et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology[J]. Ann Rheum Dis, 2002, 61(8): 718-722.
  • 10Galon J, Franchimont D, Hiroi N, et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells[J]. FASEB J, 2002. 16(1): 61-71.

共引文献58

同被引文献37

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部